BioLineRx Ltd. – American Depositary Shares (NASDAQ:BLRX) has traded as high as $6.47 during today’s trading session and last traded at $6.04 for a gain of 83.59% from yesterday’s close! BLRX shares have traded as high as $6.19 over the past 52 weeks. Get my next ALERT 100% FREE

BLRX, a biopharmaceutical development company, announced today it has signed a worldwide, exclusive license agreement with Genoscience, a French company focused on viral disease therapeutics, to develop and commercialize BL-8020, an orally available treatment for Hepatitis C.

BL-8020 has been developed for anti-viral therapy by Professor Philippe Halfon, Co-Founder and President of Genoscience. Prof. Halfon is a founder of several biotechnology companies and is world renowned for his work on HIV (AIDS virus), HPV (human papilloma virus causing cervical cancer) and Hepatitis. Read more

Spanish Broadcasting System Inc (NASDAQ:SBSA) has traded as high as $6.97 during today’s trading session and last traded at $6.75 for a gain of 22.06% from yesterday’s close. SBSA shares have traded as high as $12.10 over the past 52 weeks, which is 44.2% off that high at last traded stock price.

Spanish Broadcasting System, Inc. is the largest publicly traded Hispanic-controlled media and entertainment company in the United States. SBS owns and/or operates 21 radio stations located in the top U.S. Hispanic markets of New York, Los Angeles, Miami, Chicago, San Francisco and Puerto Rico, airing the Tropical, Mexican Regional, Spanish Adult Contemporary and Hurban format genres.

The Bon-Ton Stores, Inc. (NASDAQ:BONT) has traded as high as $3.79 during today’s trading session and last traded at the high of the day for a gain of 17.34% from yesterday’s close. BONT shares have traded as high as $17.49 over the past 52 weeks, which is 78.3% off that high at last traded stock price.

BONT today announced the appointment of Brendan L. Hoffman, 43, to the position of President and Chief Executive Officer of the Company, effective February 7, 2012. He will also be elected to the Board of Directors (the “Board”). Mr. Hoffman replaces President and Chief Executive Officer Bud Bergren, who is a current member of the Board of Directors and who will transition to the role of the Chairman of the Board of the Company. Upon Mr. Bergren’s transition to Chairman of the Board, Tim Grumbacher, currently serving as Executive Chairman of the Board, will remain a Director of the Company.

Brendan L. Hoffman, President and Chief Executive Officer of The Bon-Ton Stores, Inc. (Photo: Business Wire)

Mr. Hoffman was the Chief Executive Officer and President of Lord & Taylor L.L.C. since October 2008. Prior to this, he served six years as President and Chief Executive Officer of Neiman Marcus Direct, a subsidiary of The Neiman Marcus Group Inc., where he oversaw the growth of neimanmarcus.com and the launch and growth of bergdorfgoodman.com. Mr. Hoffman also served as Vice President of Last Call Clearance Division at Neiman Marcus from August 2000 to December 2002 and as a Divisional Merchandise Manager of Bergdorf Goodman Inc. from October 1998 to August 2000.

TearLab Corporation (USA) (NASDAQ:TEAR) has traded as high as $1.85 during today’s trading session and last traded at $1.71 for a gain of 36.8% from yesterday’s close. TEAR shares have traded as high as $2.40 over the past 52 weeks, which is 28.75% off that high at last traded stock price. Get my next ALERT 100% FREE

TEAR announced today that, after reviewing and accepting labeling submitted to it by the Company, the U.S. Food and Drug Administration (“FDA”) has now granted Waiver categorization under the Clinical Laboratory Improvement Amendments of 1988 (“CLIA”) for the TearLab® Osmolarity System.

Elias Vamvakas, TearLab’s Chief Executive Officer, commented, “We believe that, with CLIA Waiver and Medicare reimbursement in place, and with the updated American Academy of Ophthalmology’s Preferred Practice Pattern guidelines listing tear osmolarity as a more sensitive method to diagnose Dry Eye Disease, the TearLab Osmolarity test is now well on its way toward being established as a standard of care.”

• Need fast service and cheap rates from a broker? Buy stock online at my favorite brokerage
• See today’s top stock picks and market analysis
• Want more? Check out the message board buzz for these stocks
• See what newsletters are recommending these stock picks
• Get breaking news alerts on these stocks: http://thestockmarketwatch.com/
• This newsletter has been helping traders make a killing on these stocks. Click here for a 25% discount offer.

About BeaconEquity.com

BeaconEquity.com is committed to producing the highest-quality insight and analysis of small-cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily OTC stocks in the stock market today, which have traditionally been shunned by Wall Street. We have particular expertise with renewable energy stocks, biotech stocks, oil stocks, green energy stocks and internet stocks. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Beacon Equity Group Disclaimer

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Beaconequity.com is a wholly-owned subsidiary of BlueWave Advisors.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.